JASN Podcast

In this podcast, EIC Josie Briggs talks with Giuseppe Remuzzi about the NEPHSTROM Trial & the next steps in translational work to test the possibility that mesenchymal stem cells can be used as a therapeutic agent to promote repair of kidney damage.

In the episode, EIC Josie Briggs discusses a randomized control trial addressing the impact of sodium bicarbonate on the vascular dysfunction in CKD and an observational case control study of the impact of antibiotic use on kidney stone formation.

In this podcast, Dr. Briggs discusses with Dr. Andrew Rule his latest study showing the need to revise our estimate of the number of nephrons in the human kidney.

In this episode, JASN Associate Editor Katalin Susztak talks with Dr. Susan Quaggin about work from her laboratory on ischemic injury and translational targets in the Angiopoietin-Tie 2 pathway.

In the May podcast, JASN Editor in Chief Josie Briggs talks with Deputy Editor Tom Hostetter about the   unsolved problem of the chemical causes of the uremic syndrome. The discussion is prompted by a new study reporting correlation of outcomes in CKD with protein carbamylation, a chemical change caused by cyanate, a breakdown product of urea. The editors tackle the old question: does urea matter?

In this podcast, EIC Dr Briggs discusses two studies on kidney transplantation with Dr. John Gill. Topics discussed include novel molecular markers and the role of HLA-DQ mismatches, work suggesting new approaches to reduce chronic graft loss.

This episode, JASN's inaugural podcast, is a conversation with Drs. Tanjala Purnell and Deidre Crews, about the impact of the COVID-19 epidemic on kidney patients, particularly the disproportionate impact on people of color.

In this podcast, JASN Editorial Fellow Dr. Madhav Menon, discusses with Dr. Andrew Malone a novel application of RNAseq to the transplant biopsy.

In this podcast, JASN Editorial Fellow Dr. Erin Barreto interviews lead author, Dr. Mahboob Rahman, about his recent paper on blood pressure patterns detected with ambulatory blood pressure monitoring and implications on outcomes for CKD patients.

This episode of the JASN Podcast is a discussion between JASN EIC, Josie Briggs and Deputy Editor, Mark Knepper about the question: Does SARS CoV2 Infect the Kidney?

Every issue of JASN includes Highlights, which are short summaries of 5-6 articles hand picked by the EIC for their interest and impact.

Every issue of JASN includes Highlights, which are short summaries of 5-6 articles hand picked by the EIC for their interest and impact.

Every issue of JASN includes Highlights, which are short summaries of 5-6 articles hand picked by the EIC for their interest and impact.

Every issue of JASN includes Highlights, which are short summaries of 5-6 articles hand-picked by the EIC for their interest and impact.

Every issue of JASN includes Highlights, which are short summaries of 5-6 articles hand-picked by the EIC for their interest and impact.

Two papers published this month in JASN provide new insights into these unsolved questions: Why is the risk of atherosclerotic cardiovascular disease so high in kidney patients? Why is the podocyte slit diaphragm so vulnerable to immunological injury?

The June issue of JASN features new population level data from CMS on the real burden of the pandemic for dialysis and transplant patients in the US. These grim numbers remind us of the important role nephrologists play in Advance Care Planning.

A discussion between Dr. Magdalene Assimon, one of the JASN editorial fellows and study authors Dr. Pablo Garcia and Dr. Shuchi Anand on their recent JASN paper titled, "SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey."

The extracellular matrix (ECM) biomechanically regulates nephrogenesis, and abnormal ECM is a histologic feature of kidney aging and disease. Two reports in this issue use state-of-the-art methods to characterize the ECM in development, aging and disease.

Transplant candidates with top 20% Estimated Post-Transplant Survival (EPTS) scores are prioritized to receive optimal deceased-donor kidneys. A study found fewer than half of eligible ESKD patients w/ top 20% EPTS scores were on transplant waiting list.

A few articles in each issue are chosen by the EIC for their interest. The issue highlights include: laminin-521 –a novel GBM autoantigen, iron biomarkers & mortality in nondialysis kidney disease, & disparities among hemodialysis patients with COVID-19.

A conversation with EIC, Josie Briggs and leading nephrology clinical trialist, Vlado Perkovic - on the next generation of clinical trials in nephrology.

Each issue of JASN contains Highlights, short summaries of a few of the articles in the issue, chosen by the EIC as of special interest to our readers.

Each issue of JASN contains Highlights, short summaries of a few of the articles in the issue, chosen by the EIC as of special interest to our readers.